A case of subclinical immune checkpoint inhibitor-associated myocarditis in non-small cell lung cancer

BACKGROUND: Immune checkpoint inhibitors (ICIs) have been widely used in the treatment of cancer. Moreover, immune-related adverse events (irAEs) have become a new clinical challenge. ICI-associated myocarditis is a rare but fatal condition among diverse organ injuries, and early recognition and eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yue, Liu, Cuixia, Jin, Shaojun, Yi, Zihan, Wang, Chao, Pan, Xiaohong, Huang, Huaqiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103507/
https://www.ncbi.nlm.nih.gov/pubmed/37060029
http://dx.doi.org/10.1186/s12890-023-02417-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103507/
https://www.ncbi.nlm.nih.gov/pubmed/37060029
http://dx.doi.org/10.1186/s12890-023-02417-4

Ejemplares similares